Romed Klinikum Rosenheim

At Romed Klinikum Rosenheim, the clinical trial portfolio strongly focuses on respiratory tract diseases, especially chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, and severe viral lung infections. The studies are designed to test new therapies, assess symptom control, and improve long-term lung function and outcomes.

• New treatment options for COPD and exacerbation prevention
• Therapies aimed at slowing fibrotic lung disease progression
• Supportive care approaches for serious viral lung infection

These trials reflect an active interest in both chronic and acute lung conditions, with a clear emphasis on better disease management and patient outcomes.

The site also contributes to research in neoplasms, including metastatic colorectal cancer, breast cancer, ovarian cancer, non-small-cell lung cancer, and gastroesophageal junction adenocarcinoma. The trials are mainly aimed at comparing treatment strategies, improving survival, and refining treatment selection in advanced or high-risk disease.

• Studies in colorectal cancer exploring better treatment sequencing and disease control
• Research in breast cancer focused on recurrence risk and treatment effectiveness
• Trials in ovarian cancer and gastroesophageal cancer evaluating more effective cancer therapies

This oncology work combines treatment evaluation with efforts to improve outcomes for patients facing aggressive or recurrent cancers.

Clinical research in digestive system diseases includes celiac disease, colon cancer, rectal cancer, and recovery-related issues after pancreatoduodenectomy. The studies are designed to improve symptom relief, support postoperative recovery, and strengthen treatment strategies for gastrointestinal cancers.

• Trials addressing persistent symptoms in celiac disease
• Research on recovery and digestive complications after pancreatic surgery
• Studies testing better approaches for colon and rectal cancer care

These projects show a broad commitment to both chronic digestive disorders and cancer-related care within the gastroenterology field.

Another important area at this site is female urogenital diseases and pregnancy-related conditions, with a particular emphasis on ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. The trials are focused on testing new treatment combinations and improving disease control in advanced gynecologic cancers.

• Studies for newly diagnosed advanced ovarian cancer
• Research on treatment maintenance and recurrence prevention
• Comparisons of cancer therapies to improve progression-free survival

This work supports more personalized and effective care for women with complex gynecologic malignancies.

Clinical trials in virus diseases at the site address severe respiratory infections, including HSV-1 detection in ventilated patients and other serious viral lung infections requiring oxygen support. The main goal is to evaluate therapies that may reduce complications, prevent worsening illness, and improve survival in critically ill patients.

• Studies in intensive care patients with viral pneumonia
• Trials testing treatments to prevent progression to more severe respiratory support
• Research aimed at improving outcomes in hospitalized patients with viral lung infection

These investigations connect infectious disease care with critical care medicine and respiratory support.

Some trials at Romed Klinikum Rosenheim also focus on broader pathological conditions and clinical symptoms, such as treatment persistence, postoperative complications, and lung function decline. These studies are intended to better understand patient experience, support adherence, and improve everyday clinical outcomes.

• Research on treatment persistence and patient support
• Studies targeting postoperative digestive complications
• Trials measuring changes in lung function and symptom burden

This area brings together practical questions from routine care and targeted clinical research to improve how patients respond to treatment.